Search
A class of drugs originally developed to treat certain neurological disorders appears to boost the production of red blood cells.
Researchers at MSK pioneered many discoveries in 2023. Read about some of the most important findings.
Memorial Sloan Kettering Cancer Center (MSK) today announced that Selwyn M. Vickers, MD, FACS, an internationally recognized pancreatic cancer surgeon and researcher, a pioneer in cancer health disparities research, and an academic medical leader, has joined the institution as President and Chief Executive Officer.
MSK medical oncologist David Straus is looking for less-intensive treatments for Hodgkin lymphoma, a type of blood cancer most commonly found in young adults.
The online resource will serve as a benchmark for researchers studying metabolism and cancer.
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments.
Mark Denisiuk was diagnosed with acute myeloid leukemia in the spring of 2021. He found hope when he enrolled in an early trial of an entirely new kind of drug that’s based on lab research conducted at MSK.
Nine students will don caps and gowns to celebrate their academic achievements and receive their PhDs from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK).
Discover how Sunrise Association Day Camps are transforming summer for children affected by cancer.